Basket | Login | Register


LM11A-31-BHS (coming soon)

Phase II trials

Scientific title

Study of LM11A-31-BHS in patients with mild to moderate probable Alzheimer's disease

Study sponsor

PharmatrophiX Inc.


Alzheimer’s disease


Phase IIa

Name of drug


Link to full text

Please note that an accessible easy read version of this study is not yet available. The pharmaceutical company running this trial and a member of the European Working Group of People with Dementia are currently reviewing this document.



Last Updated: Thursday 07 February 2019


  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union